مروری بر کاربردهای پزشکی سیانوباکتری‌ها

نوع مقاله : مقاله مروری

نویسندگان

1 استادیار، گروه بیوتکنولوژی، دانشکده‌ی علوم و فناوری‌های همگرا، واحد علوم و تحقیقات، دانشگاه آزاد اسلامی، تهران، ایران

2 دانشجوی کارشناسی ارشد، گروه بیوتکنولوژی، دانشکده‌ی علوم و فناوری‌های همگرا، واحد علوم و تحقیقات، دانشگاه آزاد اسلامی، تهران، ایران

چکیده

مقاله مروری




مقدمه: متابولیت‌های ثانویه حاصل از سیانوباکتری‌ها، کاربردهای بیوتکنولوژی فراوانی در زمینه‌ی پزشکی دارند. با این حال بر خلاف سایر منابع میکروبی تولید‌کننده‌ی محصولات طبیعی، سیانوباکتری‌ها در طول تاریخ کمتر مورد توجه قرار گرفته‌اند. به همین دلیل هدف از این مقاله‌ی مروری این بود که با بررسی دستاوردهای اخیر در زمینه‌ی پزشکی و درمانی سیانوباکتری‌ها، پتانسیل دارویی این موجودات ارزشمند را بیشتر شناخت.
روش‌ها: در مقاله‌ی حاضر، مقالات مرتبط منتشر شده در سال‌های 2020-2023 در بانک‌های اطلاعاتی Springer، Science Direct،  Scopusو John Wiley جهت به دست آوردن آخرین یافته‌ها در زمینه‌ی کاربردهای پزشکی سیانوباکتری‌ها مورد بررسی قرار گرفتند. در این مقاله مروری با جستجو در سایت MeSH، کلمات کلیدی مناسب انتخاب گردید و بر اساس آن‌ها، 66 مقاله جدید مروری و تحقیقاتی، جمع‌آوری گردید.
یافته‌ها: بسیاری از مولکول‌های فعال زیستی مشتق شده از سیانوباکتری‌ها، طیف وسیعی از فعالیت‌های ضد میکروبی، ضد باکتریایی، ضد ویروسی، ضد التهابی، ضد تومور، ضد مالاریا، سرکوب‌کننده‌ی سیستم ایمنی و ضد (Human immunodeficiency virus) HIV و همچنین مهار پروتئاز را نشان می‌دهند. در واقع سیانوباکتری‌ها به عنوان یک منبع میکروبی برای تولید داروهای جدید، بسیار با ارزش هستند و فقط به مواد معدنی اولیه برای رشد نیاز دارند.
نتیجه‌گیری: امروزه می‌توان با بهره‌برداری از تکنیک‌های مدرن و استخراج‌های مبتنی بر امواج مایکروویو، امکان جداسازی سریع مواد شیمیایی زیست‌فعال از سیانوباکتری‌ها را فراهم آورد. این روش‌ها، می‌توانند نقش مهمی در توسعه‌ی درمان‌های جدید و همچنین بهره‌برداری بیشتر از سیانوباکتری‌ها در پیشرفت‌های فناوری سبز در آینده فراهم آورد.

تازه های تحقیق

بهاره نوروزی: Google Scholar, PubMed

حسن بیرانوند: Google Scholar

کلیدواژه‌ها

موضوعات


عنوان مقاله [English]

A Review of Medical Applications of Cyanobacteria

نویسندگان [English]

  • Bahareh Nowruzi 1
  • Hassan Beiranvand 2
1 Assisstant Professor, Department of Biotechnology, School of Converging Sciences and Technologies, Islamic Azad University, Science and Research Branch, Tehran, Iran
2 MSc Student, Department of Biotechnology, School of Converging Sciences and Technologies, Islamic Azad University, Science and Research Branch, Tehran, Iran
چکیده [English]

Background: Secondary metabolites derived from cyanobacteria exhibit diverse applications in biotechnology, particularly in the field of medicine. Throughout history, cyanobacteria have received less attention compared to other microbial sources of natural products despite their potential. Therefore, this review aims to explore the recent advancements in the medical and therapeutic applications of cyanobacteria, aiming to further understand the valuable medicinal potential of these organisms.
Methods: In this paper, relevant articles published between 2020 and 2023 were scrutinized in databases such as Springer, ScienceDirect, Scopus, and John Wiley to obtain the latest findings regarding the medical applications of cyanobacteria. Utilizing the MeSH database, appropriate keywords were identified, leading to the selection of 66 recent reviews and research articles for comprehensive analysis.
Findings: Biologically active molecules derived from cyanobacteria have a wide range of activities, including antimicrobial, antibacterial, antiviral, anti-inflammatory, antitumor, antimalarial, immunosuppressive, anti-HIV, and protease inhibitory activities. Indeed, cyanobacteria serve as a valuable microbial source for the production of novel drugs, requiring only basic minerals for growth.
Conclusion: Modern techniques and microwave-assisted extraction methods enable the rapid isolation of bioactive compounds from cyanobacteria. These approaches play a pivotal role in in developing new therapies and further utilization of cyanobacteria in advancing green technologies in the future.

کلیدواژه‌ها [English]

  • Cyanobacteria
  • Biotechnology
  • Pharmaceutical preparations
  • Therapeutics
  1. Stelmasiewicz M, Świątek Ł, Gibbons S, Ludwiczuk A. Bioactive compounds produced by endophytic microorganisms associated with bryophytes-The "bryendophytes". Molecules 2023; 28(7): 3246.
  2. Issa Q. Application of microbial polysaccharides in pharmaceutical field: A review. South Asian Res J Bio Appl Biosc 2023; 5(3): 47-54.
  3. Pereira L, Valado A. Algae-derived natural products in diabetes and its complications-current advances and future prospects. Life (Basel) 2023; 13(9): 1831.
  4. Kaštovský J. Welcome to the jungle!: An overview of modern taxonomy of cyanobacteria. Hydrobiologia 2024; 851(4): 1063-77.
  5. Nowruzi B, Jalil BS, Metcalf JS. Antifungal screening of selenium nanoparticles biosynthesized by microcystin-producing Desmonostoc alborizicum. BMC Biotechnol 2023; 23(1): 41.
  6. Nowruzi B, Aljashamy H, Zaker Firuzabad M. Study
    of pesticidal activity of bioactive compounds of Desmonostoc alborizicum in improving the antioxidative activity of Glycine max to cowpea aphid. Arthropod-Plant Interactions .2023; 17(6): 811-24.
  7. Nowruzi B, Nemati F. Evaluation of hydrolytic enzymes and antifungal activity of extracellular bioactive compounds of Desmonostoc alborizicum and Neowestiellopsis persica against Plant Pathogenic Fungi. Acta Biologica Slovenica 2023; 66(1).
  8. Khalifa SAM, Shedid ES, Saied EM, Jassbi AR, Jamebozorgi FH, Rateb ME, et al. Cyanobacteria- From the Oceans to the Potential Biotechnological and Biomedical Applications. Mar Drugs 2021; 19(5): 241.
  9. Saad MH, El-Fakharany EM, Salem MS, Sidkey NM. The use of cyanobacterial metabolites as natural medical and biotechnological tools: review article.
    J Biomol Struct Dyn 2022; 40(6): 2828-50.
  10. Śliżewska A, Żymańczyk-Duda E. Cyanobacteria as valuable tool in biotechnology. Catalysts 2021; 11(11): 1259.
  11. Nowruzi B, Fattahi M, Jahangirzadeh M. A review of the use of microalgae in the production of cosmetics [in Persian]. J Dermatol Cosmetic 2023; 14(2): 114-29.
  12. Carpine R, Sieber S. Antibacterial and antiviral metabolites from cyanobacteria: their application and their impact on human health. Current Res Biotechnol 2021; 3: 65-81.
  13. Nowruzi B, Jafari Porzani S, Anvar AAJ. Study on the effect of phycoerythrin on antimicrobial activity and shelf-life extension of the Nile Tilapia (Oreochromis niloticus) at refrigerator temperature. Arch Razi Institute 2023; 78(6): 1811-21.
  14. Iry N, Nowruzi B, Ghazi S. Study of the effect of phycocyanin pigment on physicochemical, sensory, microbial and antioxidant properties of cheese. Res Innovat Food Sci Technol 2023; 12(1): 55-76.
  15. Srivastava R, Prajapati R, Kanda T, Yadav S, Singh N, Yadav S, et al. Phycochemistry and bioactivity of cyanobacterial secondary metabolites. Mol Biol Rep 2022; 49(11): 11149-67.
  16. Ferrazzano GF, Papa C, Pollio A, Ingenito A, Sangianantoni G, Cantile T. Cyanobacteria and microalgae as sources of functional foods to improve human general and oral health. Molecules 2020; 25(21): 5164.
  17. de Oliveira DT, da Costa AAF, Costa FF, da Rocha Filho GN, do Nascimento LAS. Advances in the biotechnological potential of Brazilian marine microalgae and cyanobacteria. Molecules 2020; 25(12): 2908.
  18. Nowruzi B, Jafari Porzani S. Toxic compounds produced by cyanobacteria belonging to several species of the order Nostocales: A review. J Appl Toxicol 2020.
  19. Robles-Bañuelos B, Durán-Riveroll LM, Rangel-López E, Pérez-López HI, González-Maya L. Marine cyanobacteria as sources of lead anticancer compounds: A review of families of metabolites with cytotoxic, antiproliferative, and antineoplastic effects. Molecules 2022; 27(15): 4814.
  20. Biondi N, Martina MR, Centini M, Anselmi C, Tredici MR. Hot springs cyanobacteria endowed with biological activities for cosmetic applications: Evaluation of on-site collected communities and isolated strains. Cosmetics 2023; 10(3): 81.
  21. Pradhan B, Nayak R, Patra S, Bhuyan PP, Dash SR, Ki JS, et al. Cyanobacteria and algae-derived bioactive metabolites as antiviral agents: Evidence, mode of action, and scope for further expansion; A comprehensive review in light of the SARS-CoV-2 outbreak. Antioxidants (Basel) 2022; 11(2): 354.
  22. Ibrahim TNBT, Feisal NAS, Kamaludin NH, Cheah WY, How V, Bhatnagar A, et al. Biological active metabolites from microalgae for healthcare and pharmaceutical industries: A comprehensive review. Bioresour Technol 2023; 372: 128661.
  23. Kini S, Divyashree M, Mani MK, Mamatha BS. Algae and cyanobacteria as a source of novel bioactive compounds for biomedical applications. In: Singh PK, Kumar A, Shrivastava AK, editors. Advances in cyanobacterial biology. Amsterdam, Netherlands: Elsevier; 2020. p. 173-94.
  24. Gozari M, Alborz M, El-Seedi HR, Jassbi AR. Chemistry, biosynthesis and biological activity of terpenoids and meroterpenoids in bacteria and fungi isolated from different marine habitats. Eur J Med Chem 2021; 210: 112957.
  25. Hassan S, Meenatchi R, Pachillu K, Bansal S, Brindangnanam P, Arockiaraj J, et al. Identification and characterization of the novel bioactive compounds from microalgae and cyanobacteria for pharmaceutical and nutraceutical applications. J Basic Microbiol 2022; 62(9): 999-1029.
  26. Ganeshkumar A, Gonçale JC, Rajaram R, Junqueira JC. Anti-candidal marine natural products: A review. J Fungi (Basel) 2023; 9(8): 800.
  27. Macario IP, Veloso T, Fernandes AP, Martins M, Frankenbach S, Serodio J, et al. Are cyanobacteria a nearly immortal source of high market value compounds? J Chem Technol Biotechnol 2023; 98(3): 734-43.
  28. Géron A, Werner J, Wattiez R, Matallana-Surget S. Towards the discovery of novel molecular clocks in Prokaryotes. Crit Rev Microbiol 2023: 1-13.
  29. Remya RR, Julius A, Ramadoss R, Parthiban S, Bharath N, Pavana B, et al. Pharmacological activities of natural products from marine seaweed turbinaria ornata: A review. J Nanomater 2022; 2022.
  30. Fernandes C, Ribeiro R, Pinto M, Kijjoa A. Absolute stereochemistry determination of bioactive marine-derived cyclopeptides by liquid chromatography methods: An update review (2018-2022). Molecules 2023; 28(2): 615.
  31. Elkhateeb WA, El-Ghwas DE, Daba GM. Mushrooms and lichens the factory of important secondary metabolites. J Biomed Res Environ Sci 2023; 4(6): 1072-82.
  32. Sowmya N, Mohanty D, Nirosha B, Kumar NU, Patra PK. A systematic review of metallic nanoparticles: Synthesis, biological activities & applications. J Pharmaceut Negative Results 2023; 14(2): 2525-33.
  33. García-Beltrán JM, Arizcun M, Chaves-Pozo E. Antimicrobial peptides from photosynthetic marine organisms with potential application in aquaculture. Mar Drugs 2023; 21(5): 290.
  34. Jung F, Braune S, Jung CHG, Krüger-Genge A, Waldeck P, Petrick I, et al. Lipophilic and hydrophilic compounds from Arthrospira platensis and its effects on tissue and blood cells-An overview. Life (Basel) 2022; 12(10): 1497.
  35. Singh S, Kate BN, Banerjee UC. Bioactive compounds from cyanobacteria and microalgae: an overview. Crit Rev Biotechnol 2005; 25(3): 73-95
  36. Nandhini SN, Sisubalan N, Vijayan A, Karthikeyan C, Gnanaraj M, Gideon DAM, et al. Recent advances in green synthesized nanoparticles for bactericidal and wound healing applications. Heliyon 2023; 9(2): e13128.
  37. Shahbaz A, Hussain N, Saba S. Actinomycetes, cyanobacteria, and fungi: a rich source of bioactive molecules. In: Kumar A, Bilal M, Kumari M, editors. Microbial biomolecules. Amsterdam, Netherlands: Elsevier; 2023. p. 113-33.
  38. Dawiec-Liśniewska A, Podstawczyk D, Bastrzyk A, Czuba K, Pacyna-Iwanicka K, Okoro OV, et al. New trends in biotechnological applications of photosynthetic microorganisms. Biotechnol Adv 2022; 59: 107988.
  39. Olguín EJ, Sánchez-Galván G, Arias-Olguín II, Melo FJ, González-Portela RE, Cruz L, et al. Microalgae-Based biorefineries: Challenges and future trends to produce carbohydrate enriched biomass, High-added value products and bioactive compounds. Biology (Basel) 2022; 11(8): 1146.
  40. Karageorgou D, Zygouri P, Tsakiridis T, Hammami MA, Chalmpes N, Subrati M, et al. Green synthesis and characterization of silver nanoparticles with high antibacterial activity using cell extracts of cyanobacterium pseudanabaena/limnothrix Nanomaterials (Basel) 2022; 12(13): 2296.
  41. Koksharova OA, Safronova NA. Non-proteinogenic amino acid β-N-methylamino-L-alanine (BMAA): Bioactivity and ecological significance. Toxins (Basel) 2022; 14(8): 539.
  42. Gentscheva G, Milkova-Tomova I, Pehlivanov I, Gugleva V, Nikolova K, Petkova N, et al. Chemical characterization of selected algae and cyanobacteria from Bulgaria as sources of compounds with antioxidant activity. Appl Sci 2022; 12(19): 9935.
  43. Karjee PK, Nayak R, Pradhan B, Jena M. Antibacterial activity of microalgal extracts: A review of the natural drug discovery. Res J Berhampur Univ 2022; 4: 1-7.
  44. Żymańczyk-Duda E, Samson SO, Brzezińska-Rodak M, Klimek-Ochab M. Versatile applications of cyanobacteria in biotechnology. Microorganisms 2022; 10(12): 2318.
  45. Alvariño R, Alonso E, Bornancin L, Bonnard I, Inguimbert N, Banaigs B, et al. Biological activities of cyclic and acyclic B-type laxaphycins in SH-SY5Y human neuroblastoma cells. Mar Drugs 2020;
    18(7): 364.
  46. Anvar SAA, Nowruzi B, Afshari G. A review of the Application of nanoparticles biosynthesized by microalgae and cyanobacteria in medical and veterinary sciences. Iranian J Veterinary Med 2023; 17(1): 1-18.
  47. Al-Yousef HM, Amina M. Phytoconstituents and pharmacological activities of cyanobacterium Fischerella ambigua. Arabian J Chem 2021; 14(6): 103153.
  48. Dembitsky VM. Hydrobiological aspects of fatty acids: Unique, rare, and unusual fatty acids incorporated into linear and cyclic lipopeptides and their biological activity. Hydrobiology 2022; 1(3): 331-432.
  49. Adenubi OT, Famuyide IM, McGaw LJ, Eloff JN. Lichens: An update on their ethnopharmacological uses and potential as sources of drug leads.
    J Ethnopharmacol 2022; 298: 115657.
  50. Nawaz T, Gu L, Fahad S, Saud S, Jiang Z, Hassan S, et al. A comprehensive review of the therapeutic potential of cyanobacterial marine bioactives: Unveiling the hidden treasures of the sea. Food
    Energy Security 2023; e495.
  51. Gentscheva G, Nikolova K, Panayotova V, Peycheva K, Makedonski L, Slavov P, et al. Application of arthrospira platensis for medicinal purposes and the food industry: A review of the literature. Life (Basel) 2023; 13(3): 845.
  52. Guerreiro A, Andrade MA, Menezes C, Vilarinho F, Dias E. Antioxidant and cytoprotective properties of cyanobacteria: Potential for biotechnological applications. Toxins (Basel) 2020; 12(9): 548.
  53. Dembitsky VM. Fascinating furanosteroids and their pharmacological profile. Molecules 2023; 28(15): 5669.
  54. Nowruzi B, Zandieh S. Cyanobacteria are a rich source of anticancer drugs [in Persian]. JNACMS 2023; 1(1): 50-65.
  55. Seyed MA, Ayesha S. Marine-derived pipeline anticancer natural products: A review of their pharmacotherapeutic potential and molecular mechanisms. Future J Pharmaceutical Sci 2021; 7(1): 1-14.
  56. Rojas V, Rivas L, Cárdenas C, Guzmán F. Cyanobacteria and eukaryotic microalgae as emerging sources of antibacterial peptides. Molecules 2020; 25(24): 5804.
  57. Dembitsky VM. Hydrobiological aspects of saturated, methyl-branched, and cyclic fatty acids derived from aquatic ecosystems: Origin, distribution, and biological activity. Hydrobiology 2022; 1(1): 89-110.
  58. Górska S, Maksymiuk A, Turło J. Selenium-containing polysaccharides-structural diversity, biosynthesis, chemical modifications and biological activity. App Sci 2021; 11(8): 3717.
  59. Scotti C, Barlow JW. Natural products containing the nitrile functional group and their biological activities. Natural Product Communication 2022; 17(5)
  60. Fratelli C, Burck M, Amarante MCA, Braga ARC. Antioxidant potential of nature's “something blue”: something new in the marriage of biological activity and extraction methods applied to C-phycocyanin. Trends Food Sci Technol 2021; 107: 309-23.
  61. Li Y, Naman CB, Alexander KL, Guan H, Gerwick WH. The chemistry, biochemistry and pharmacology of marine natural products from leptolyngbya, a chemically edowed genus of cyanobacteria. Mar Drugs 2020; 18(10): 508.
  62. Miguel SP, Ribeiro MP, Otero A, Coutinho P. Application of microalgae and microalgal bioactive compounds in skin regeneration. Algal Res 2021; 58: 102395.
  63. Dembitsky VM. Biological activity and structural diversity of steroids containing aromatic rings, phosphate groups, or halogen atoms. Molecules 2023; 28(14): 5549
  64. Prasanna R, Sood A, Jaiswal P, Nayak S, Gupta V, Chaudhary V, et al. Rediscovering cyanobacteria as valuable sources of bioactive compounds. Prikl Biokhim Mikrobiol 2010; 46(2): 133-47.
  65. Shaaban H. Cyanobacteria: Their biological activities and interesting medical applications: Review. Am J Biomed Sci Res 2022; 17(4): 423-34.